AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
CyberArk’s surge, Wiz and Cato prepare for IPOs: Israeli cyber firms ready for the next big move
2
Insight Partners hit by cyber attack with possible data leaks
3
Cybereason CEO accuses Mnuchin, SoftBank of forcing company toward bankruptcy
4
Israel-China tech ties persist amid political tensions
5
Riskified cuts staff as struggles continue
More news

Johnson & Johnson

7 stories about Johnson & Johnson
ניר ברקת שר הכלכלה ו אלי ברקת

Riding the V-Wave exit: Who are the big winners?

21.08.24|Meir Orbach
The pharmaceutical giant Johnson & Johnson announced on Tuesday the purchase of the Israeli medical device company for up to $1.7 billion. BRM is the largest shareholder in the company and is expected to receive at least $100 million. The second largest shareholder is Pontifax VC of Tomer Kariv and Ran Nussbaum. Other notable investors include Ilan Grinboim and Prof. Benad Goldwasser.
ג'ונסון אנד ג'ונסון ג'ונסון _alt ג'ונסון

Johnson & Johnson to acquire Israeli medical device maker V-Wave for up to $1.7 billion

20.08.24|Meir Orbach
V-Wave's device is implanted in the heart through a minimally invasive procedure to help reduce heart failure and other events. 
הדמיה חיסון תרופה קורונה covid 19

Place your bets: Which company will reach a Covid-19 vaccine first?

02.08.20|Sophie Shulman
Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game
אורן כהן מייסד חברת OrthoSpin

Orthopedic Brace Startup OrthoSpin Raises $5 Million

31.03.20|Adi Pick
OrthoSpin develops an electric brace designed to help with bone lengthening, setting complex fractures, and correcting deformities
ועידת MIND THE DATA 2016 אייל גורה מייסד ויו״ר Zebra Medical

Zebra Medical Partners With Johnson & Johnson Subsidiary

19.12.19|Meir Orbach
DePuy Synthes, a subsidiary of Johnson & Johnson, develops surgical devices used to treat fractures and orthopedic injuries
נאסדק

Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen

24.04.19|CTech
The two companies will collaborate on the research of a “therapeutic area of mutual interest”
חקר DNA מעבדה

Phage Therapies Company BiomX Signs Johnson & Johnson Collaboration

13.12.18|Lilach Baumer
Bacteriophages are viruses that invade bacterial cells and can be used to treat bacterial infections. Phage therapy is often discussed as an alternative to traditional antibiotics